Motor neurone disease (MND) is a uncommon condition that affects the brain and nerves. It causes weakness that gets worse over time, more…
The company expects that if the stage three trial goes well, that the US Food and Drug Administration may give regulatory approval for mass use among doctors and patients. The trial will be measured by the ALSFR-S score responder analysis and final data is expected by 2019.
BrainStorm’s first two clinical trials of its stem cell therapy treatment, called NurOwn, were conducted at Jerusalem’s Hadassah hospital and also in the United States.
https://alsadotorg.wordpress.com/ (is http://www.alsa.org/)
Marcus Foundation $13M grant targets osteoarthritis with stem cell therapies
‘Reprogrammed’ stem cells to be tested in people with Parkinson’s
Apply AI to Accelerate Answer ALS Research
http://www.alsa.org/news/media/press-releases/gns-healthcare-partnership-073118.html
ALS = Mitochondria malfunction
wiki
Mitochondria in amyotrophic lateral sclerosis: a trigger and a target
The role of mitochondria in amyotrophic lateral sclerosis
In this paper, we propose that glyphosate, the active ingredient in Roundup®, plays a role in ALS, mainly through mistakenly substituting for glycine during protein synthesis, disruption of mineral homeostasis as well as setting up a state of dysbiosis.
Does Glyphosate Acting as a Glycine Analogue Contribute To ALS?
https://www.magicmobility.com.au/wheelchair/extreme-x8/
https://www.paterakis.net/
https://draculis.gr/
Μας είπαν για έρευνες που γίνονται (με πρωτοπόρους τον Καρούση στο Ισραήλ και την Καραγεωργίου στο Γεννηματά). (src)
ref - http://hcbb.bioacademy.gr/
Ασθενείς με πλάγια αμυοτροφική σκλήρυνση (ALS) παρουσιάζουν εμφανή βελτίωση της κλινικής τους εικόνας με τη χρήση βλαστοκυττάρων και αναμένουν την έγκριση της μεθόδου από τον FDA των ΗΠΑ
We all have people close to us who have been affected by a neurodegenerative disease.
http://amylyx.com/
New CRISPR base-editing technology slows ALS progression in mice
https://www.sciencedaily.com/releases/2020/02/200226130523.htm